Alume Biosciences Inc

Biotech LA Jolla, CA

About

Issuer

Entity type
Corporation
Jurisdiction
Delaware
Sector
Biotech
Headquarters
LA Jolla, CA
Street
2223 Avenida DE LA Playa
Zip
92037

Offering

Total offering
$8M
Amount sold
$110k
First sale
Mar 24, 2026
Min investment
$50k
Securities
Other
Federal exemption
Rule 506(b)
Investors so far
2

How this filing compares

Ranked #13 of 47 Biotech filings in April 2026 by offering amount.

Median Biotech filing in April 2026: $3M. This offering is 2.7× the median.

Other California filings this week: A-Star Fund III, LP, Artie Technologies Inc., BAY HILLS CAPITAL PARTNERS VI-A, L.P., BAY HILLS CAPITAL PARTNERS VI, L.P., Cityview Real Estate Partners VIII, LP

Leadership

Quyen Nguyen — Executive Officer (also: Director)

Brett Berman — Executive Officer (also: Director)

Dan Bradbury — Director

Kim Kamdar — Director

Magda Marquet — Director

Also named on: Acurion, Inc.

Jean-Pierre Millon — Director

James Schmidt — Executive Officer

Kaveri Parker — Executive Officer

Filing details

Alume Biosciences Inc filed a Form D with the SEC on April 6, 2026.

Other newest Biotech companies

Other newest companies in California